{"ticker": {"uuid": "3a7bd1a2-a84a-498b-960e-1a7fa4a85b9d", "symbol": "600056", "name": "China Meheco Group Co., Ltd.", "exchange": "SHH", "country": "CN", "sector": "Healthcare", "industry": "Medical Distribution"}, "articles": [{"title": "China National Pharmaceutical Group Co., Ltd. (SHA: 600056) announced that its subsidiary's marketing application for the chemical active pharmaceutical ingredient ezetimibe has been approved.", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOdVViU0RKVVYwSnhXUk1MWGUyQ3JMOTZkbFc4ZXRpZW5IZXRnMzZnTnZHU29TenVpMXIwNjlJclctRGtUZWtZSkg4UlBTMWVXcjlyVk5PcFY0emJLZ3M5N1NJVzFXNzVLV0JkcGljVVB0dkJ1T1oxLUd0MmFiTmhzS0RsRWlGblNxbXF3UXpSanJkdU1hZDRxemxZbUxmODR6dkxubm85OHFvTnlubHc?oc=5", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-16T11:54:09+00:00", "published_display": "16 Jul 2026 11:54", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of China Meheco Group Co., Ltd. Class A \u2013 SSE:600056", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNc0tXLXhpY1A0OUFaRVl0QkRfdmFNTGp2c21VR0sxOS1zLVByNklCQ3dERTJITmltN2ZEaVRrMUFnMWlnajh6czRwWEw3TkZMbXI5M1V2bVdvYWxBeDltUi15UkRBWENRa21PMVJ1MVVTMWdFRVNDWUxYR2E3WnhUQVVuVjdLc3hXMUtTQ2FHTUFUbHlIaG5aSGxQOA?oc=5", "source_name": "TradingView", "published_at": "2026-07-09T14:27:56+00:00", "published_display": "09 Jul 2026 14:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Stock Trader\u2019s Guide To China\u2019s Potential Exit From Covid Zero", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOczNVWVEtaWlXaGl2bmJWLXJTaUZfRjJtd25aUWRTMzRja0l1SVVEM3ZEcTlQZ3NoRzd1dUl4eXE1SVJleGdVUTJoS0txOFZIN1R1ZFYxdUhtRjB0TTJOdkZpZW1QR0RvZWpiWmZZSUNWZWxuZmlzdXZOUEpZUHUxNE5GWUdLV0xYY1pQZExqRTlpTFN0bnhLdkZaRmp0blZBNWRMY3RXRDFXT1FP0gG0AUFVX3lxTFBvVG9aWlo0T0lYUnN2SmtLS1lfcWhfZnNiWWRfZG1vMngwdHB4MnVQZDZQbllXMnNLOHNFX2NEbGRVbXM0RnFiOXJJT1RKdEhVNjRxRlBINnNFX0thM0xjbG1wN2lrRmYxdzJ1SXRqd3V0WWt6SEtqR1VmNTVWNWlpRnJHMEtwTDNGTXFsVkplUTdNQllUSi1fU3FGdVozUy1GczVFcUhJNS1OWVhTN2gzMmhLcg?oc=5", "source_name": "NDTV Profit", "published_at": "2022-11-05T07:00:00+00:00", "published_display": "05 Nov 2022 07:00", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "China National Pharmaceutical Group Co., Ltd. (SHA: 600056) announced that its subsidiary's marketing application for the chemical active pharmaceutical ingredient ezetimibe has been approved.", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOdVViU0RKVVYwSnhXUk1MWGUyQ3JMOTZkbFc4ZXRpZW5IZXRnMzZnTnZHU29TenVpMXIwNjlJclctRGtUZWtZSkg4UlBTMWVXcjlyVk5PcFY0emJLZ3M5N1NJVzFXNzVLV0JkcGljVVB0dkJ1T1oxLUd0MmFiTmhzS0RsRWlGblNxbXF3UXpSanJkdU1hZDRxemxZbUxmODR6dkxubm85OHFvTnlubHc?oc=5", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-16T11:54:09+00:00", "published_display": "16 Jul 2026 11:54", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of China Meheco Group Co., Ltd. Class A \u2013 SSE:600056", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNc0tXLXhpY1A0OUFaRVl0QkRfdmFNTGp2c21VR0sxOS1zLVByNklCQ3dERTJITmltN2ZEaVRrMUFnMWlnajh6czRwWEw3TkZMbXI5M1V2bVdvYWxBeDltUi15UkRBWENRa21PMVJ1MVVTMWdFRVNDWUxYR2E3WnhUQVVuVjdLc3hXMUtTQ2FHTUFUbHlIaG5aSGxQOA?oc=5", "source_name": "TradingView", "published_at": "2026-07-09T14:27:56+00:00", "published_display": "09 Jul 2026 14:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Stock Trader\u2019s Guide To China\u2019s Potential Exit From Covid Zero", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOczNVWVEtaWlXaGl2bmJWLXJTaUZfRjJtd25aUWRTMzRja0l1SVVEM3ZEcTlQZ3NoRzd1dUl4eXE1SVJleGdVUTJoS0txOFZIN1R1ZFYxdUhtRjB0TTJOdkZpZW1QR0RvZWpiWmZZSUNWZWxuZmlzdXZOUEpZUHUxNE5GWUdLV0xYY1pQZExqRTlpTFN0bnhLdkZaRmp0blZBNWRMY3RXRDFXT1FP0gG0AUFVX3lxTFBvVG9aWlo0T0lYUnN2SmtLS1lfcWhfZnNiWWRfZG1vMngwdHB4MnVQZDZQbllXMnNLOHNFX2NEbGRVbXM0RnFiOXJJT1RKdEhVNjRxRlBINnNFX0thM0xjbG1wN2lrRmYxdzJ1SXRqd3V0WWt6SEtqR1VmNTVWNWlpRnJHMEtwTDNGTXFsVkplUTdNQllUSi1fU3FGdVozUy1GczVFcUhJNS1OWVhTN2gzMmhLcg?oc=5", "source_name": "NDTV Profit", "published_at": "2022-11-05T07:00:00+00:00", "published_display": "05 Nov 2022 07:00", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 54, "total_relevant": 3, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 2, "score": 53, "total": 3, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 2.0, "count": 3}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 9.46, "latest_week": "2026-07-17", "one_week_move": 4.1, "four_week_move": 5.0, "twelve_week_move": -8.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.110135, "market_dynamics_buy_signal": false, "relative_strength": -5.952121, "fair_value_gap": -12.2, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 46.0571, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+4.1% over one week, +5.0% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 61, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "\u5bcc\u9014\u725b\u725b", "count": 1}, {"label": "TradingView", "count": 1}, {"label": "NDTV Profit", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 3}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 3}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "3", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+4.1% over one week, +5.0% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "China National Pharmaceutical Group Co., Ltd. (SHA: 600056) announced that its subsidiary's marketing application for the chemical active pharmaceutical ingredient ezetimibe has been approved."}], "updated_at": "2026-07-21T15:05:54.626092+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}